Total Payments
$16,540
2024 Payments
$380.52
Companies
25
Transactions
274
Medicare Patients
1,533
Medicare Billing
$103,374
Payment Breakdown by Category
Food & Beverage$6,392 (38.6%)
Consulting$3,129 (18.9%)
Research$2,589 (15.7%)
Other$2,340 (14.1%)
Travel$1,835 (11.1%)
Education$255.06 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,392 | 254 | 38.6% |
| Consulting Fee | $3,129 | 5 | 18.9% |
| Unspecified | $2,589 | 2 | 15.7% |
| Honoraria | $2,340 | 1 | 14.1% |
| Travel and Lodging | $1,835 | 6 | 11.1% |
| Education | $255.06 | 6 | 1.5% |
Payments by Type
General
$13,950
272 transactions
Research
$2,589
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $4,724 | 49 | $0 (2022) |
| Lupin Inc. | $2,500 | 1 | $0 (2018) |
| BioCryst Pharmaceuticals, Inc. | $2,250 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $1,437 | 42 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,139 | 13 | $0 (2024) |
| OptiNose US, Inc. | $811.01 | 3 | $0 (2020) |
| GlaxoSmithKline, LLC. | $766.89 | 46 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $582.91 | 17 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $427.86 | 21 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $318.91 | 31 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $380.52 | 10 | Genentech USA, Inc. ($138.74) |
| 2023 | $721.85 | 28 | AstraZeneca Pharmaceuticals LP ($222.33) |
| 2022 | $367.28 | 17 | Regeneron Healthcare Solutions, Inc. ($138.82) |
| 2021 | $949.41 | 29 | AstraZeneca Pharmaceuticals LP ($359.24) |
| 2020 | $3,935 | 53 | BioCryst Pharmaceuticals, Inc. ($2,250) |
| 2019 | $973.45 | 39 | AstraZeneca Pharmaceuticals LP ($301.84) |
| 2018 | $3,729 | 45 | Lupin Inc. ($2,500) |
| 2017 | $5,483 | 53 | CSL Behring ($4,078) |
All Payment Transactions
274 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: RESPIRATORY | ||||||
| 07/16/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: Immunology | ||||||
| 06/27/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $109.80 | General |
| Category: Immunology | ||||||
| 06/04/2024 | ADMA BioManufacturing LLC | — | Consulting Fee | Cash or cash equivalent | $30.45 | General |
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $91.50 | General |
| Category: Respiratory | ||||||
| 05/21/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 02/27/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Respiratory | ||||||
| 02/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: RESPIRATORY | ||||||
| 12/08/2023 | ADMA BioManufacturing LLC | — | Consulting Fee | Cash or cash equivalent | $29.92 | General |
| 09/26/2023 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 09/12/2023 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: IMMUNOLOGY | ||||||
| 08/23/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: GENETIC DISEASE | ||||||
| 08/23/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Respiratory | ||||||
| 08/17/2023 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $30.76 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Respiratory | ||||||
| 07/10/2023 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Immunology | ||||||
| 06/19/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Respiratory | ||||||
| 06/13/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/07/2023 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: IMMUNOLOGY | ||||||
| 06/06/2023 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Immunology | ||||||
| 05/25/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $96.00 | General |
| Category: Respiratory | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER CLINICAL STUDY TO ASSESS THE EFFICACY AND SAFETY OF TWICE DAILY ADMINISTRATION OF FLUTICASONE PROPIONATE 100 MCG AND SALMETEROL XINAFOATE 50 MCG DRY POWDER INHALER COMPARED TO ADMINISTRATION WITH ADVAIR DISKUS 10050 MCG TWICE DAILY AND PLACEBO IN PATIENTS 12 YEARS OF AGE AND OLDER WITH REVERSIBLE PERSISTENT ASTHMA INCLUDING A 3-WEEK OPEN-LABEL EXTENSION TO ASSESS INHALER ROBUSTNESS | Lupin Inc. | $2,500 | 1 |
| A MULTICENTER, RANDOMIZED, PARALLEL-GROUP, PLACEBO-CONTROLLED, 4-WEEK CLINICAL ENDPOINT BIOEQUIVALENCE STUDY COMPARING FLUTICASONE PROPIONATE/SALMETEROL 100/50 MCG INHALATION POWDER (CIPLA LTD., INDIA) WITH ADVAIR DISKUS 100/50 MCG (GLAXOSMITHKLINE, USA) IN ASTHMA PATIENTS. | CIPLA USA INC. | $89.31 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 364 | 865 | $101,946 | $23,406 |
| 2022 | 9 | 323 | 801 | $101,521 | $24,505 |
| 2021 | 11 | 429 | 1,117 | $94,371 | $30,965 |
| 2020 | 12 | 417 | 1,091 | $51,872 | $24,497 |
Total Patients
1,533
Total Services
3,874
Medicare Billing
$103,374
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 24 | 27 | $622.48 | $553.36 | 88.9% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 14 | 14 | $630.00 | $547.26 | 86.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 24 | 27 | $907.90 | $448.63 | 49.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 163 | 209 | $19,553 | $10,320 | 52.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 40 | 48 | $6,444 | $3,741 | 58.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 19 | 19 | $3,561 | $2,078 | 58.4% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 21 | 195 | $6,149 | $1,988 | 32.3% |
| 95115 | Injection of incremental dosages of allergen | Office | 2020 | 22 | 271 | $7,264 | $1,515 | 20.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 16 | 16 | $1,865 | $1,218 | 65.3% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 38 | 39 | $954.72 | $744.04 | 77.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 15 | 17 | $2,530 | $740.20 | 29.3% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 24 | 28 | $1,038 | $679.33 | 65.4% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2020 | 11 | 196 | $1,299 | $642.14 | 49.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 37 | 38 | $908.20 | $627.76 | 69.1% |
| 95012 | Measurement of inhaled nitric oxide gas | Office | 2020 | 11 | 15 | $306.75 | $203.01 | 66.2% |
About Dr. Kraig Jacobson, M.D
Dr. Kraig Jacobson, M.D is a Allergy & Immunology healthcare provider based in Eugene, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1255323515.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kraig Jacobson, M.D has received a total of $16,540 in payments from pharmaceutical and medical device companies, with $380.52 received in 2024. These payments were reported across 274 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($6,392).
As a Medicare-enrolled provider, Jacobson has provided services to 1,533 Medicare beneficiaries, totaling 3,874 services with total Medicare billing of $103,374. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Eugene, OR
- Active Since 08/22/2005
- Last Updated 12/28/2010
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1255323515
Products in Payments
- Haegarda (Biological) $4,394
- ADVAIR (Drug) $2,500
- Xhance (Drug) $811.01
- NUCALA (Biological) $674.56
- DUPIXENT (Biological) $510.16
- FEVIPIPRANT (Drug) $460.81
- FASENRA (Biological) $354.66
- SYMBICORT (Drug) $312.20
- Hizentra (Biological) $303.50
- FASENRA (Drug) $283.43
- CINRYZE (Drug) $277.65
- BREZTRI (Drug) $215.32
- CUVITRU (Biological) $177.21
- Xolair (Biological) $164.86
- DUPIXENT DUPILUMAB INJECTION (Biological) $164.20
- XOLAIR (Biological) $141.95
- TAKHZYRO (Biological) $140.22
- Orladeyo (Drug) $118.61
- UTIBRON (Drug) $115.24
- CUTAQUIG (Biological) $114.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Eugene
Dr. Maxwell Li, M.d, M.D
Allergy & Immunology — Payments: $5,998
Allergy & Immunology $5,998
Dr. Sarah Kehl, M.d, M.D
Allergy & Immunology — Payments: $2,847
Allergy & Immunology $2,847
Jason Friesen, Md, MD
Allergy & Immunology — Payments: $2,065
Allergy & Immunology $2,065
Dr. Richard Buck, Md, MD
Allergy & Immunology — Payments: $778.68
Allergy & Immunology $778.68
Lisa Wheatley, Md, MD
Allergy & Immunology
Allergy & Immunology